The U.S. Food and Drug Administration today approved the MicroTransponder Vivistim Paired VNS System (Vivistim System), a first-of-its-kind, drug-free rehabilitation system intended to treat moderate ...
With funding from the Department of Defense, research facilities in Ohio and New Jersey will conduct a multi-site study of transcranial stimulation for recovery of upper limb function in individuals ...
In a recent article published in Nature Medicine, researchers performed an open-label phase I trial wherein they applied deep brain stimulation (DBS) to the cerebellar dentate nucleus (DN) to promote ...
The US Food and Drug Administration (FDA) has approved the Vivistim System (MicroTransponder), a first-of-its kind vagus nerve stimulation (VNS) system intended to treat moderate-to-severe upper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback